OncLive TV

Dr. Sun on the KEYNOTE-062 Design in Advanced Gastric/GEJ Cancer

January 14th 2021

Weijing Sun, MD, FACP, discusses the design of the KEYNOTE-062 trial in advanced gastric/gastroesophageal junction cancer.

Dr. Berlin on Unmet Needs in Pancreatic Cancer

January 14th 2021

Jordan D. Berlin, MD, discusses unmet needs in pancreatic cancer.

Dr. Ailawadhi on the Emergence of T-Cell Engagers in Multiple Myeloma

January 13th 2021

Sikander Ailawadhi, MD, discusses the emergence of T-cell engagers in multiple myeloma.

Dr. Mai on Barriers of Genetic Testing in CRC

January 13th 2021

Phuong L. Mai, MD, discusses barriers of genetic testing in colorectal cancer.

Dr. Lin on CAR T-Cell Therapy–Related Toxicities in Multiple Myeloma

January 13th 2021

Yi Lin, MD, PhD, discusses CAR T-cell therapy–related toxicities in multiple myeloma.

Dr. Sullivan on Sequencing Targeted Therapy and Immunotherapy in Melanoma

January 13th 2021

Ryan Sullivan, MD, discusses treatment sequencing with targeted therapy and immunotherapy in melanoma.

Dr. Janjigian on the Importance of Routine HER2 Testing in Gastric/GEJ Cancer

January 13th 2021

Yelena Y. Janjigian, MD, discusses the importance of routine HER2 testing in gastric/gastroesophageal cancer.

Dr. Fonseca on the Emergence of MRD in Multiple Myeloma

January 13th 2021

Rafael Fonseca, MD, discusses the emergence of minimal residual disease in multiple myeloma.

Dr. Schweizer on the Results of the HERO Trial in Prostate Cancer

January 13th 2021

Michael Schweizer, MD, discusses the results of the HERO trial in prostate cancer.

Dr. DeAngelo on the Utility of Moxetumomab Pasudotox in HCL

January 13th 2021

Daniel J. DeAngelo, MD, PhD, discusses the utility of moxetumomab pasudotox-tdfk in hairy cell leukemia.

End of data

x